首页> 外文期刊>Nature reviews Cancer >Every step of the way: integrins in cancer progression and metastasis.
【24h】

Every step of the way: integrins in cancer progression and metastasis.

机译:方式的每一步:癌症进展和转移中的整合蛋白。

获取原文
获取原文并翻译 | 示例
       

摘要

Cell adhesion to the extracellular matrix is fundamental to tissue integrity and human health. Integrins are the main cellular adhesion receptors that through multifaceted roles as signalling molecules, mechanotransducers and key components of the cell migration machinery are implicated in nearly every step of cancer progression from primary tumour development to metastasis. Altered integrin expression is frequently detected in tumours, where integrins have roles in supporting oncogenic growth factor receptor (GFR) signalling and GFR-dependent cancer cell migration and invasion. In addition, integrins determine colonization of metastatic sites and facilitate anchorage-independent survival of circulating tumour cells. Investigations describing integrin engagement with a growing number of versatile cell surface molecules, including channels, receptors and secreted proteins, continue to lead to the identification of novel tumour-promoting pathways. Integrin-mediated sensing, stiffening and remodelling of the tumour stroma are key steps in cancer progression supporting invasion, acquisition of cancer stem cell characteristics and drug resistance. Given the complexity of integrins and their adaptable and sometimes antagonistic roles in cancer cells and the tumour microenvironment, therapeutic targeting of these receptors has been a challenge. However, novel approaches to target integrins and antagonism of specific integrin subunits in stringently stratified patient cohorts are emerging as potential ways forward.
机译:细胞对细胞外基质的粘附性是组织完整性和人类健康的基础。整联蛋白是主要的蜂窝粘附受体,其通过多方刻录的作用作为信号分子,电池迁移机制的机制和关键部件与从原发性肿瘤发育到转移的癌症进展几乎每一步。在肿瘤中经常检测到改变的整联蛋白表达,其中整联蛋白具有支持致癌生长因子受体(GFR)信号传导和GFR依赖性癌细胞迁移和侵袭的作用。此外,整联蛋白确定转移性位点的定植,并促进循环肿瘤细胞的锚定存活。描述整联蛋白与越来越多的通道细胞表面分子的参与,包括通道,受体和分泌蛋白,继续导致鉴定新型肿瘤促进途径。整联素介导的肿瘤基质的传感,加强和重塑是癌症进展的关键步骤,支持侵袭,获取癌症干细胞特征和耐药性。鉴于整联蛋白的复杂性及其适应性和有时癌细胞中的拮抗作用以及肿瘤微环境,这些受体的治疗靶向是挑战。然而,在严格分层的患者群体中靶向整合蛋白和特定整联蛋白亚基的靶向整合蛋白和对拮抗的方法正在出现潜在的方式。

著录项

  • 来源
    《Nature reviews Cancer》 |2018年第9期|共16页
  • 作者

    Hellyeh Hamidi; Johanna Ivaska;

  • 作者单位

    Turku Centre for Biotechnology University of?Turku and ?bo Akademi University Turku Finland;

    Turku Centre for Biotechnology University of?Turku and ?bo Akademi University Turku Finland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号